HC Wainwright & Co. Maintains Buy on Dyadic International, Lowers Price Target to $6
HC Wainwright & Co. analyst Vernon Bernardino maintains Dyadic International (NASDAQ:DYAI) with a Buy and lowers the price target from $7 to $6.
Earnings Scheduled For March 29, 2022
Companies Reporting Before The Bell
• 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
DYAI: Don’t Put All Your Eggs in One Basket
By John Vandermosten, CFA
NASDAQ:DYAI
READ THE FULL DYAI RESEARCH REPORT
Watching Dyadic International; Zack’s Small-Cap Research Issues Report ‘DYAI: Jumpin’ Janssen Jamboree’
https://scr.zacks.com/news/news-details/2021/DYAI-Jumpin-Janssen-Jamboree-article/default.aspx
28 Stocks Moving In Friday’s Mid-Day Session
Gainers
Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.
HC Wainwright & Co. Initiates Coverage On Dyadic International with Buy Rating, Announces Price Target of $7
HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Dyadic International (NASDAQ:DYAI) with a Buy rating and announces Price Target of $7.